Mark McDade's Net Worth
Estimate Recalculated Nov 5, 2024 07:03PM EST
Who is Mark McDade
Mark McDade has an estimated net worth of $6.71 Million. This is based on reported shares across multiple companies, which include Tourmaline Bio, Inc., VALENTIS INC, Icosavax, Inc., CYTOKINETICS INC, PHILLIPS EDISON GROCERY CENTER REIT II, INC., Dermira, Inc., Jasper Therapeutics, Inc., Aimmune Therapeutics, Inc., PROTEIN DESIGN LABS INC/DE, and FIVE PRIME THERAPEUTICS INC.
SEC CIK
Mark McDade's CIK is 0001242126
Past Insider Trading and Trends
2004 was Mark McDade's most active year for acquiring shares with 71 total transactions. Mark McDade's most active month to acquire stocks was the month of May. 2004 was Mark McDade's most active year for disposing of shares, totalling 78 transactions. Mark McDade's most active month to dispose stocks was the month of December. 2022 saw Mark McDade paying a total of $299,797.50 for 84,547 shares, this is the most they've acquired in one year. In 2020 Mark McDade cashed out on 279,496 shares for a total of $5,718,824.08, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
